PATH-34. Assessment of BRAF alterations and recommended treatments in CNS tumors with BRAF alterations
Sign Up to like & getrecommendations! Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0986
Abstract: Comprehensive genomic profiling (CGP) has been reimbursed in Japan since June 2019, enabling treatment decisions based on genetic alterations. However, only 10–15% of patients receive genomically matched therapy, and its clinical utility remains limited. Our… read more here.
Keywords: cns tumors; treatment; recommended therapy; braf alterations ... See more keywords